Clarence H. Smith - 10 Aug 2022 Form 4 Insider Report for HAVERTY FURNITURE COMPANIES INC (HVT)

Signature
Jenny H. Parker, Attorney-in-Fact
Issuer symbol
HVT
Transactions as of
10 Aug 2022
Net transactions value
-$329,242
Form type
4
Filing time
12 Aug 2022, 13:41:26 UTC
Previous filing
01 Jul 2022
Next filing
30 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HVT Common Stock Sale $329,242 -11,260 -36% $29.24 19,618 10 Aug 2022 Direct F1
holding HVT Common Stock 7,850 10 Aug 2022 By Georgia Limited Partnership
holding HVT Common Stock 29,689 10 Aug 2022 By Spouse
holding HVT Class A Common Stock 112,036 10 Aug 2022 Direct
holding HVT Class A Common Stock 1,950 10 Aug 2022 By Spouse
holding HVT Class A Common Stock 603,497 10 Aug 2022 By Villa Clare, LP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HVT PRSUs 2020 44,800 10 Aug 2022 Common Stock 44,800 Direct F2
holding HVT PRSUs 2020.1 7,680 10 Aug 2022 Common Stock 7,680 Direct F3
holding HVT PRSUs 2021 37,352 10 Aug 2022 Common Stock 37,352 Direct F4
holding HVT PRSUs 2021.1 6,670 10 Aug 2022 Common Stock 6,670 Direct F5
holding HVT RSUs 2019 725 10 Aug 2022 Common Stock 725 Direct F6
holding HVT RSUs 2020 2,640 10 Aug 2022 Common Stock 2,640 Direct F7
holding HVT RSUs 2021 4,402 10 Aug 2022 Common Stock 4,402 Direct F8
holding HVT RSUs 2022 7,973 10 Aug 2022 Common Stock 7,973 Direct F9
holding HVT Phantom Stock 5,541 10 Aug 2022 Common Stock 5,541 $0.000000 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $29.00 to $29.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 Performance Restricted Stock Units ("PRSUs") award granted 1/23/2020. Each PRSU represents a contingent right to receive one share of HVT common stock and was earned based on EBITDA for the year ended December 31, 2020 and will vest on February 28, 2023.
F3 Performance Restricted Stock Units ("PRSUs") award granted 1/23/2020. Each PRSU represents a contingent right to receive one share of HVT common stock and was earned based on comparable store sales for the year ended December 31, 2020 and will vest on February 28, 2023.
F4 Performance Restricted Stock Units ("PRSUs") award granted 1/21/2021. Each PRSU represents a contingent right to receive one share of HVT common stock and was earned based on EBITDA for the year ended December 31, 2021 and will vest on February 28, 2024.
F5 Performance Restricted Stock Units ("PRSUs") award granted 1/21/2021. Each PRSU represents a contingent right to receive one share of HVT common stock and was earned based on consolidated sales for the year ended December 31, 2021 and will vest on February 28, 2024.
F6 Restricted Stock Units ("RSUs") award granted 1/31/2019 under the 2014 Long-Term Incentive Plan. RSUs vest ratably over 4 years, beginning 5/8/2020. Each RSU is equivalent to one share of common stock upon vesting.
F7 Restricted Stock Units granted 1/23/2020 and vest ratably over 3 years beginning 5/8/2021. Each RSU is equivalent to one share of common stock upon vesting.
F8 Restricted Stock Units granted 1/21/2021 and vest ratably over 3 years beginning 5/8/2022. Each RSU is equivalent to one share of common stock upon vesting.
F9 Restricted Stock units granted 1/26/2022 and vest ratably over 3 years beginning 5/8/2023. Each RSU is equivalent to one share of common stock upon vesting.
F10 Deferred under Directors' Deferred Compensation Plan. Settlement will occur upon the earlier to occur of (i) termination of service on the Board of Directors, or (ii) death.